Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced today the enrollment of the first patient in the Food and Drug Administration (FDA) approved prospective feasibility study, STEMI Door to Unloading (DTU) with Impella CP® system in acute myocardial infarction.

New research out of Canada points to a trend showing atrial fibrillation and flutter (AFF) kills more women than men.

A new study from Europe evaluated whether survival rates for patients with heart failure are better than those with common cancers—and the results were comparable.

A new study from the Cincinnati Children's Hospital Medical Center suggests that teenagers who consume too much salt experience significant changes in their blood vessels that predispose them to cardiovascular disease later in life.

Nearly 20 percent of adults at the highest risk of having an MI did not believe they needed to improve their physical health, according to a population-based study in Canada.

Physicians at the Buffalo Niagara Medical Campus in Buffalo, New York, have begun using AliveCor’s Kardia Pro, a device that allows them to remotely monitor patients’ heart health, reports The Buffalo News.

Physicians often use body mass index (BMI) to assess people’s cardiovascular disease risk. A recent study suggests, though, that BMI may not be the best way to determine cardiometabolic abnormalities, particularly among minority groups.

Australian officials recalled Abbott Vascular’s Absorb Bioresorbable Vascular Scaffold System after research linked it to elevated rates of heart attack and blood clots, reports the Daily Mail.